new drug discovery agreement

BioFocus and Ono Pharmaceutical Signed a New Drug Discovery Agreement on CNS Disorders.
Nov 30, 2012
BioFocus, the Galapagos' service division, and Ono Pharmaceutical have signed a new drug discovery agreement focusing on CNS disorders. BioFocus managing director and Galapagos Services SVP Dr. Chris Newton said, "This project plays to ...

Tags: BioFocus, CNS disorders, new drug discovery agreement